| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 1.922.734.293 $ | +283.073.026 $ | +77,3 % | 118 | 1.823.011.658 $ | +150.616.384 $ | +18,6 % | 112 | 1.941.694.991 $ | +593.482.134 $ | +55,1 % | 105 | |||
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 155.867.152 $ | -840.266 $ | -0,5 % | 1 | 156.707.418 $ | +33.631.966 $ | +27,3 % | 1 | 123.075.452 $ | +10.131.894 $ | +9,0 % | 1 |
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 94.949.961 $ | +7.518.665 $ | +8,6 % | 1 | 87.431.296 $ | -68.150.179 $ | -43,8 % | 1 | 155.581.475 $ | +73.985.761 $ | +90,7 % | 1 |
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 72.609.040 $ | -65.163.826 $ | -47,3 % | 1 | 137.772.866 $ | -446.884 $ | -0,3 % | 1 | 138.219.750 $ | +134.650 $ | +0,1 % | 1 | |
| GSK plc | GSK | → 0 | Stark | 25.257.686 $ | -73.266.122 $ | -74,4 % | 1 | 98.523.808 $ | -32.889.710 $ | -25,0 % | 1 | 131.413.518 $ | +39.895.069 $ | +43,6 % | 1 |
| Abivax S.A. | ABVX | → 0 | Neutral | 121.783.649 $ | +17.735.648 $ | +17,0 % | 1 | 104.048.001 $ | +15.335.797 $ | +17,3 % | 1 | 88.712.204 $ | +52.502.439 $ | +145,0 % | 1 |
| Encompass Health Corp | EHC | → 0 | Neutral | 103.800.973 $ | +85.025.293 $ | +452,8 % | 1 | 18.775.680 $ | +7.426.554 $ | +65,4 % | 1 | 11.349.126 $ | +11.349.126 $ | 1 | |
| ENSIGN GROUP, INC | ENSG | → 0 | Stark | 96.513.264 $ | +93.538.922 $ | +3.144,9 % | 1 | 2.974.342 $ | +2.974.342 $ | 1 | |||||
| Natera, Inc. | NTRA | → 0 | Neutral | 47.722.810 $ | -29.215.943 $ | -38,0 % | 1 | 76.938.753 $ | +309.752 $ | +0,4 % | 1 | 76.629.001 $ | -7.018.094 $ | -8,4 % | 1 |
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Schwach | 61.168.871 $ | -6.239.259 $ | -9,3 % | 1 | 67.408.130 $ | -2.227.582 $ | -3,2 % | 1 | 69.635.712 $ | +16.291.086 $ | +30,5 % | 1 |
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 66.454.865 $ | +9.738.997 $ | +17,2 % | 1 | 56.715.868 $ | +17.748.737 $ | +45,5 % | 1 | 38.967.131 $ | +9.115.221 $ | +30,5 % | 1 |
| iSHARES TRUST | → 0 | 61.413.472 $ | +41.366.672 $ | +206,4 % | 1 | 20.046.800 $ | +20.046.800 $ | 1 | |||||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Neutral | 15.268.079 $ | +1.316.537 $ | +9,4 % | 1 | 13.951.542 $ | -41.511.611 $ | -74,8 % | 1 | 55.463.153 $ | +13.936.630 $ | +33,6 % | 1 |
| Vaxcyte, Inc. | PCVX | → 0 | Schwach | 36.619.110 $ | -17.085.745 $ | -31,8 % | 1 | 53.704.855 $ | -1.558.038 $ | -2,8 % | 1 | 55.262.893 $ | +4.043.065 $ | +7,9 % | 1 |
| Brookdale Senior Living Inc. | BKD | → 0 | Neutral | 54.649.202 $ | +5.831.370 $ | +11,9 % | 1 | 48.817.832 $ | +44.772.348 $ | +1.106,7 % | 1 | 4.045.484 $ | +4.045.484 $ | 1 | |
| IONIS PHARMACEUTICALS INC | IONS | → 0 | Schwach | 52.702.794 $ | +5.238.405 $ | +11,0 % | 1 | 47.464.389 $ | +4.885.963 $ | +11,5 % | 1 | 42.578.426 $ | +7.339.223 $ | +20,8 % | 1 |
| Travere Therapeutics, Inc. | TVTX | → 0 | Neutral | 45.389.656 $ | +29.268.713 $ | +181,6 % | 1 | 16.120.943 $ | -28.774.584 $ | -64,1 % | 1 | 44.895.527 $ | +11.024.351 $ | +32,5 % | 1 |
| HCA Healthcare, Inc. | HCA | → 0 | Stark | 38.307.472 $ | +813.140 $ | +2,2 % | 1 | 37.494.332 $ | -7.265.404 $ | -16,2 % | 1 | 44.759.736 $ | -2.846.804 $ | -6,0 % | 1 |
| CareTrust REIT, Inc. | CTRE | → 0 | Stark | 43.255.805 $ | +43.255.805 $ | 1 | |||||||||
| DANAHER CORP /DE/ | DHR | → 0 | Neutral | 42.639.097 $ | +22.957.232 $ | +116,6 % | 1 | ||||||||
| QIAGEN N.V. | QGEN | → 0 | Sehr stark | 2.662.710 $ | -38.243.355 $ | -93,5 % | 1 | 40.906.065 $ | +40.906.065 $ | 1 | |||||
| VERTEX PHARMACEUTICALS INC / MA | VRTX | → 0 | Neutral | 40.188.600 $ | +40.188.600 $ | 1 | |||||||||
| BRUKER CORP | BRKR | → 0 | Neutral | 11.006.561 $ | +6.780.051 $ | +160,4 % | 1 | 4.226.510 $ | -32.697.790 $ | -88,6 % | 1 | 36.924.300 $ | +14.599.479 $ | +65,4 % | 1 |
| Avantor, Inc. | AVTR | → 0 | Stark | 23.318.410 $ | -13.085.930 $ | -35,9 % | 1 | 36.404.340 $ | +24.867.304 $ | +215,5 % | 1 | ||||
| WELLTOWER INC. | WELL | → 0 | Neutral | 19.817.205 $ | -15.959.013 $ | -44,6 % | 1 | 35.776.218 $ | +35.776.218 $ | 1 | |||||
| Liquidia Corp | LQDA | → 0 | Schwach | 34.176.424 $ | +8.611.650 $ | +33,7 % | 1 | 25.564.774 $ | +7.994.085 $ | +45,5 % | 1 | 17.570.689 $ | +6.518.571 $ | +59,0 % | 1 |
| HEALTHPEAK PROPERTIES, INC. | DOC | → 0 | Stark | 32.548.980 $ | +32.548.980 $ | 1 | |||||||||
| INSULET CORP | PODD | → 0 | Neutral | 22.657.236 $ | -7.464.457 $ | -24,8 % | 1 | 30.121.693 $ | +8.886.691 $ | +41,8 % | 1 | 21.235.002 $ | +7.155.679 $ | +50,8 % | 1 |
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 18.656.530 $ | -10.282.556 $ | -35,5 % | 1 | 28.939.086 $ | +5.594.505 $ | +24,0 % | 1 | 23.344.581 $ | +12.918.767 $ | +123,9 % | 1 |
| GERON CORP | GERN | → 0 | Neutral | 23.958.300 $ | -4.105.676 $ | -14,6 % | 1 | 28.063.976 $ | +4.752.798 $ | +20,4 % | 1 | 23.311.178 $ | +6.050.545 $ | +35,1 % | 1 |
| COMMUNITY HEALTH SYSTEMS INC | CYH | → 0 | Stark | 26.267.680 $ | +756.474 $ | +3,0 % | 1 | 25.511.206 $ | +726.544 $ | +2,9 % | 1 | 24.784.662 $ | +2.474.998 $ | +11,1 % | 1 |
| INSMED Inc | INSM | → 0 | Schwach | 26.208.156 $ | +10.837.276 $ | +70,5 % | 1 | 15.370.880 $ | +15.370.880 $ | 1 | |||||
| OMEGA HEALTHCARE INVESTORS INC | OHI | → 0 | Stark | 23.055.521 $ | -2.608.977 $ | -10,2 % | 1 | 25.664.498 $ | +25.664.498 $ | 1 | |||||
| EXACT SCIENCES CORP | EXAS | → 0 | 24.544.818 $ | +24.544.818 $ | 1 | ||||||||||
| CHEMED CORP | CHE | → 0 | Stark | 24.462.062 $ | +12.730.591 $ | +108,5 % | 1 | 11.731.471 $ | +11.731.471 $ | 1 | |||||
| ELI LILLY & Co | LLY | → 0 | Stark | 24.127.734 $ | +6.652.104 $ | +38,1 % | 1 | 17.475.630 $ | +6.059.304 $ | +53,1 % | 1 | 11.416.326 $ | +11.416.326 $ | 1 | |
| Viking Therapeutics, Inc. | VKTX | → 0 | Schwach | 23.519.987 $ | +15.739.348 $ | +202,3 % | 1 | 7.780.639 $ | +7.780.639 $ | 1 | |||||
| BIO-TECHNE Corp | TECH | → 0 | Neutral | 1.364.110 $ | -5.215.215 $ | -79,3 % | 1 | 6.579.325 $ | -15.615.863 $ | -70,4 % | 1 | 22.195.188 $ | -10.712.182 $ | -32,6 % | 1 |
| Cidara Therapeutics, Inc. | → 0 | 21.806.482 $ | +21.806.482 $ | 1 | |||||||||||
| TENET HEALTHCARE CORP | THC | → 0 | Neutral | 21.364.349 $ | +15.795.139 $ | +283,6 % | 1 | 5.569.210 $ | +5.569.210 $ | 1 | |||||
| UNITEDHEALTH GROUP INC | UNH | → 0 | Sehr stark | 21.257.396 $ | +10.433.796 $ | +96,4 % | 1 | 10.823.600 $ | -9.267.555 $ | -46,1 % | 1 | 20.091.155 $ | -1.600.591 $ | -7,4 % | 1 |
| Beta Bionics, Inc. | BBNX | → 0 | Neutral | 19.578.740 $ | +5.402.063 $ | +38,1 % | 1 | 14.176.677 $ | -6.489.966 $ | -31,4 % | 1 | 20.666.643 $ | +20.666.643 $ | 1 | |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | → 0 | Neutral | 20.604.124 $ | -6.941.667 $ | -25,2 % | 1 | ||||||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 18.972.094 $ | +18.972.094 $ | 1 | |||||||||
| MOLINA HEALTHCARE, INC. | MOH | → 0 | Neutral | 18.431.848 $ | +14.058.142 $ | +321,4 % | 1 | 4.373.706 $ | -3.517.158 $ | -44,6 % | 1 | 7.890.864 $ | +6.078.685 $ | +335,4 % | 1 |
| ICON PLC | ICLR | → 0 | Neutral | 7.601.014 $ | -9.861.493 $ | -56,5 % | 1 | 17.462.507 $ | +7.833.132 $ | +81,3 % | 1 | ||||
| HEALTHEQUITY, INC. | HQY | → 0 | Stark | 4.313.382 $ | -12.702.168 $ | -74,7 % | 1 | 17.015.550 $ | +12.050.739 $ | +242,7 % | 1 | ||||
| Pennant Group, Inc. | PNTG | → 0 | Stark | 17.007.050 $ | +7.491.865 $ | +78,7 % | 1 | 9.515.185 $ | +1.240.211 $ | +15,0 % | 1 | 8.274.974 $ | +7.317.118 $ | +763,9 % | 1 |
| GLAUKOS Corp | GKOS | → 0 | Schwach | 4.100.978 $ | -2.381.661 $ | -36,7 % | 1 | 6.482.639 $ | -10.168.312 $ | -61,1 % | 1 | 16.650.951 $ | +16.650.951 $ | 1 | |
| LTC PROPERTIES INC | LTC | → 0 | Stark | 16.173.608 $ | +4.243.539 $ | +35,6 % | 1 | 11.930.069 $ | +11.930.069 $ | 1 | |||||
| REVVITY, INC. | RVTY | → 0 | Neutral | 9.304.006 $ | +1.869.947 $ | +25,2 % | 1 | 7.434.059 $ | -8.314.616 $ | -52,8 % | 1 | 15.748.675 $ | -18.812.684 $ | -54,4 % | 1 |
| CytomX Therapeutics, Inc. | CTMX | → 0 | Schwach | 13.344.364 $ | -1.641.652 $ | -11,0 % | 1 | 14.986.016 $ | +4.305.813 $ | +40,3 % | 1 | 10.680.203 $ | +10.680.203 $ | 1 | |
| NewAmsterdam Pharma Co N.V. | NAMS | → 0 | Schwach | 9.335.712 $ | +188.406 $ | +2,1 % | 1 | 9.147.306 $ | -5.615.305 $ | -38,0 % | 1 | 14.762.611 $ | +867.055 $ | +6,2 % | 1 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | → 0 | Neutral | 14.282.513 $ | +2.545.699 $ | +21,7 % | 1 | 11.736.814 $ | +6.165.370 $ | +110,7 % | 1 | 5.571.444 $ | -2.370.687 $ | -29,8 % | 1 |
| Esperion Therapeutics, Inc. | ESPR | → 0 | 4.756.539 $ | -9.492.653 $ | -66,6 % | 1 | 14.249.192 $ | +14.249.192 $ | 1 | ||||||
| REPLIGEN CORP | RGEN | → 0 | Neutral | 1.964.872 $ | -12.266.017 $ | -86,2 % | 1 | 14.230.889 $ | +183.910 $ | +1,3 % | 1 | ||||
| AMN HEALTHCARE SERVICES INC | AMN | → 0 | Stark | 13.871.548 $ | +13.871.548 $ | 1 | |||||||||
| BIOGEN INC. | BIIB | → 0 | Stark | 13.717.365 $ | +6.466.124 $ | +89,2 % | 1 | ||||||||
| Arcutis Biotherapeutics, Inc. | ARQT | → 0 | Neutral | 3.549.008 $ | -10.035.217 $ | -73,9 % | 1 | 13.584.225 $ | +962.454 $ | +7,6 % | 1 | 12.621.771 $ | +10.520.637 $ | +500,7 % | 1 |
| SELECT MEDICAL HOLDINGS CORP | SEM | → 0 | 13.455.585 $ | +13.455.585 $ | 1 | ||||||||||
| Celcuity Inc. | CELC | → 0 | Schwach | 13.384.141 $ | +13.384.141 $ | 1 | |||||||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 13.361.124 $ | +1.864.504 $ | +16,2 % | 1 | 11.496.620 $ | -690.542 $ | -5,7 % | 1 | 12.187.162 $ | +12.187.162 $ | 1 | |
| ARDELYX, INC. | ARDX | → 0 | Neutral | 8.559.560 $ | -4.794.822 $ | -35,9 % | 1 | 13.354.382 $ | +3.355.180 $ | +33,6 % | 1 | 9.999.202 $ | +2.123.335 $ | +27,0 % | 1 |
| CENTENE CORP | CNC | → 0 | Sehr stark | 3.655.486 $ | -9.680.900 $ | -72,6 % | 1 | 13.336.386 $ | +5.324.442 $ | +66,5 % | 1 | ||||
| CG Oncology, Inc. | CGON | → 0 | Schwach | 12.807.508 $ | +12.807.508 $ | 1 | |||||||||
| BRISTOL MYERS SQUIBB CO | BMY | → 0 | Stark | 12.691.704 $ | +12.691.704 $ | 1 | |||||||||
| PALISADE BIO, INC. | PALI | → 0 | Neutral | 8.742.021 $ | +13.898 $ | +0,2 % | 1 | 8.728.123 $ | -3.942.015 $ | -31,1 % | 1 | 12.670.138 $ | +12.670.138 $ | 1 | |
| HUMANA INC | HUM | → 0 | Neutral | 12.381.745 $ | +4.067.253 $ | +48,9 % | 1 | 8.314.492 $ | +3.982.141 $ | +91,9 % | 1 | ||||
| SELECT SECTOR SPDR TRUST | → 0 | 12.366.000 $ | +12.366.000 $ | 1 | |||||||||||
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 11.862.672 $ | +4.327.944 $ | +57,4 % | 1 | 7.534.728 $ | -2.835.724 $ | -27,3 % | 1 | 10.370.452 $ | +10.370.452 $ | 1 | |
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 11.175.030 $ | +11.175.030 $ | 1 | |||||||||
| Ascendis Pharma A/S | ASND | → 0 | Stark | 11.101.153 $ | +814.242 $ | +7,9 % | 1 | 10.286.911 $ | +10.286.911 $ | 1 | |||||
| Moderna, Inc. | MRNA | → 0 | Schwach | 10.653.104 $ | +2.539.938 $ | +31,3 % | 1 | 8.113.166 $ | +215.066 $ | +2,7 % | 1 | 7.898.100 $ | +7.898.100 $ | 1 | |
| Elevance Health, Inc. | ELV | → 0 | Stark | 10.584.857 $ | -3.949.081 $ | -27,2 % | 1 | ||||||||
| Structure Therapeutics Inc. | GPCR | → 0 | Schwach | 10.535.528 $ | +3.882.193 $ | +58,3 % | 1 | 6.653.335 $ | -2.218.533 $ | -25,0 % | 1 | 8.871.868 $ | +4.212.920 $ | +90,4 % | 1 |
| MANNKIND CORP | MNKD | → 0 | Neutral | 10.504.032 $ | -465.412 $ | -4,2 % | 1 | ||||||||
| INTUITIVE SURGICAL INC | ISRG | → 0 | Neutral | 2.879.601 $ | -2.246.147 $ | -43,8 % | 1 | 5.125.748 $ | -5.103.846 $ | -49,9 % | 1 | 10.229.594 $ | +3.777.854 $ | +58,6 % | 1 |
| Definium Therapeutics, Inc. | DFTX | → 0 | Neutral | 10.216.382 $ | +7.178.717 $ | +236,3 % | 1 | 3.037.665 $ | +3.037.665 $ | 1 | |||||
| ILLUMINA, INC. | ILMN | → 0 | Neutral | 10.062.726 $ | -1.682.594 $ | -14,3 % | 1 | ||||||||
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 9.520.474 $ | +5.771.554 $ | +154,0 % | 1 | 3.748.920 $ | +3.748.920 $ | 1 | |||||
| DYNAVAX TECHNOLOGIES CORP | DVAX | → 0 | 9.319.911 $ | +2.433.188 $ | +35,3 % | 1 | |||||||||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Neutral | 8.371.092 $ | +224.857 $ | +2,8 % | 1 | ||||||||
| CATALYST PHARMACEUTICALS, INC. | CPRX | → 0 | 8.359.641 $ | +1.448.645 $ | +21,0 % | 1 | |||||||||
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Schwach | 8.355.409 $ | +8.355.409 $ | 1 | |||||||||
| Relay Therapeutics, Inc. | RLAY | → 0 | Neutral | 8.126.015 $ | +5.432.500 $ | +201,7 % | 1 | 2.693.515 $ | -1.444.584 $ | -34,9 % | 1 | 4.138.099 $ | +1.637.427 $ | +65,5 % | 1 |
| NOVO NORDISK A S | NVO | → 0 | Stark | 8.112.742 $ | -3.967.875 $ | -32,8 % | 1 | ||||||||
| REGENERON PHARMACEUTICALS, INC. | REGN | → 0 | Stark | 7.793.571 $ | -1.607.583 $ | -17,1 % | 1 | ||||||||
| Biohaven Ltd. | BHVN | → 0 | Neutral | 7.675.164 $ | +6.033.248 $ | +367,5 % | 1 | 1.641.916 $ | +1.641.916 $ | 1 | |||||
| Tyra Biosciences, Inc. | TYRA | → 0 | Neutral | 1.036.206 $ | -6.287.242 $ | -85,9 % | 1 | 7.323.448 $ | +3.508.291 $ | +92,0 % | 1 | ||||
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Schwach | 5.146.401 $ | +3.835.455 $ | +292,6 % | 1 | 1.310.946 $ | -5.984.240 $ | -82,0 % | 1 | 7.295.186 $ | +7.295.186 $ | 1 | |
| Protagonist Therapeutics, Inc | PTGX | → 0 | Schwach | 7.171.420 $ | +2.545.806 $ | +55,0 % | 1 | 4.625.614 $ | +4.625.614 $ | 1 | |||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 6.934.023 $ | +6.934.023 $ | 1 | |||||||||
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 6.766.000 $ | +6.766.000 $ | 1 | |||||||||
| Replimune Group, Inc. | REPL | → 0 | Neutral | 6.534.090 $ | +3.574.603 $ | +120,8 % | 1 | 2.959.487 $ | +2.708.121 $ | +1.077,4 % | 1 | ||||
| LB PHARMACEUTICALS INC | LBRX | → 0 | Schwach | 5.960.783 $ | +3.489.900 $ | +141,2 % | 1 | 2.470.883 $ | +2.470.883 $ | 1 | |||||
| ANAPTYSBIO, INC | ANAB | → 0 | Neutral | 4.723.852 $ | +3.221.496 $ | +214,4 % | 1 | 1.502.356 $ | -4.360.185 $ | -74,4 % | 1 | 5.862.541 $ | +5.862.541 $ | 1 | |
| Beam Therapeutics Inc. | BEAM | → 0 | Neutral | 5.707.038 $ | +5.707.038 $ | 1 | |||||||||
| ASSEMBLY BIOSCIENCES, INC. | ASMB | → 0 | Neutral | 453.695 $ | -680.975 $ | -60,0 % | 1 | 1.134.670 $ | -4.295.911 $ | -79,1 % | 1 | 5.430.581 $ | +5.430.581 $ | 1 | |
| NATIONAL HEALTH INVESTORS INC | NHI | → 0 | Neutral | 5.389.523 $ | +5.389.523 $ | 1 | |||||||||
| Invivyd, Inc. | IVVD | → 0 | Neutral | 1.951.572 $ | -1.007.682 $ | -34,1 % | 1 | 2.959.254 $ | -2.326.867 $ | -44,0 % | 1 | 5.286.121 $ | +3.034.129 $ | +134,7 % | 1 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Neutral | 5.234.700 $ | +5.234.700 $ | 1 | |||||||||
| CVS HEALTH Corp | CVS | → 0 | Stark | 5.054.915 $ | +5.054.915 $ | 1 | |||||||||
| PACS Group, Inc. | PACS | → 0 | Neutral | 5.007.684 $ | +5.007.684 $ | 1 | |||||||||
| Equillium, Inc. | EQ | → 0 | Neutral | 4.866.637 $ | +1.868.651 $ | +62,3 % | 1 | 2.997.986 $ | +2.997.986 $ | 1 | |||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Sehr schwach | 4.768.412 $ | +4.768.412 $ | 1 | |||||||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Neutral | 4.716.826 $ | +1.212.008 $ | +34,6 % | 1 | ||||||||
| NATIONAL HEALTHCARE CORP | NHC | → 0 | Neutral | 4.674.438 $ | +756.817 $ | +19,3 % | 1 | 3.917.621 $ | +3.917.621 $ | 1 | |||||
| Zenas BioPharma, Inc. | ZBIO | → 0 | Neutral | 4.394.091 $ | +870.019 $ | +24,7 % | 1 | ||||||||
| EyePoint, Inc. | EYPT | → 0 | Neutral | 4.257.610 $ | +4.257.610 $ | 1 | |||||||||
| SONIDA SENIOR LIVING, INC. | SNDA | → 0 | Neutral | 4.187.059 $ | +3.269.966 $ | +356,6 % | 1 | 917.093 $ | +917.093 $ | 1 | |||||
| enGene Therapeutics Inc. | ENGN | → 0 | Schwach | 812.380 $ | -2.664.418 $ | -76,6 % | 1 | 3.476.798 $ | -639.392 $ | -15,5 % | 1 | 4.116.190 $ | +4.116.190 $ | 1 | |
| agilon health, inc. | AGL | → 0 | Neutral | 4.050.547 $ | +2.653.736 $ | +190,0 % | 1 | 1.396.811 $ | +1.396.811 $ | 1 | |||||
| Day One Biopharmaceuticals, Inc. | DAWN | → 0 | 3.942.859 $ | +3.942.859 $ | 1 | ||||||||||
| Fortrea Holdings Inc. | FTRE | → 0 | Schwach | 3.866.398 $ | +2.019.185 $ | +109,3 % | 1 | ||||||||
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Schwach | 3.506.387 $ | +3.506.387 $ | 1 | |||||||||
| Bioventus Inc. | BVS | → 0 | Neutral | 1.452.674 $ | -2.053.478 $ | -58,6 % | 1 | 3.506.152 $ | +603.140 $ | +20,8 % | 1 | ||||
| Grace Therapeutics, Inc. | GRCE | → 0 | Neutral | 1.754.483 $ | -1.748.575 $ | -49,9 % | 1 | 3.503.058 $ | +3.503.058 $ | 1 | |||||
| Alto Neuroscience, Inc. | ANRO | → 0 | Neutral | 3.385.468 $ | +571.691 $ | +20,3 % | 1 | 2.813.777 $ | +2.813.777 $ | 1 | |||||
| UNIVERSAL HEALTH SERVICES INC | UHS | → 0 | Stark | 2.795.372 $ | -461.882 $ | -14,2 % | 1 | 3.257.254 $ | +3.257.254 $ | 1 | |||||
| Enhabit, Inc. | EHAB | → 0 | 3.204.785 $ | +1.190.123 $ | +59,1 % | 1 | 2.014.662 $ | +2.014.662 $ | 1 | ||||||
| ARS Pharmaceuticals, Inc. | SPRY | → 0 | Schwach | 3.019.826 $ | +1.925.859 $ | +176,0 % | 1 | 1.093.967 $ | -1.837.091 $ | -62,7 % | 1 | 2.931.058 $ | -6.882.878 $ | -70,1 % | 1 |
| InflaRx N.V. | IFRX | → 0 | Neutral | 2.921.115 $ | +1.348.247 $ | +85,7 % | 1 | 1.572.868 $ | -202.017 $ | -11,4 % | 1 | 1.774.885 $ | -544.166 $ | -23,5 % | 1 |
| PMV Pharmaceuticals, Inc. | PMVP | → 0 | Neutral | 2.533.811 $ | -378.155 $ | -13,0 % | 1 | 2.911.966 $ | +2.911.966 $ | 1 | |||||
| Alector, Inc. | ALEC | → 0 | Neutral | 2.861.985 $ | -42.893 $ | -1,5 % | 1 | 2.904.878 $ | +1.335.264 $ | +85,1 % | 1 | 1.569.614 $ | -2.837.012 $ | -64,4 % | 1 |
| Vor Biopharma Inc. | VOR | → 0 | Neutral | 2.755.627 $ | +2.755.627 $ | 1 | |||||||||
| Design Therapeutics, Inc. | DSGN | → 0 | Neutral | 2.749.300 $ | +2.749.300 $ | 1 | |||||||||
| Karyopharm Therapeutics Inc. | KPTI | → 0 | Sehr schwach | 2.698.220 $ | +1.027.365 $ | +61,5 % | 1 | 1.670.855 $ | +1.670.855 $ | 1 | |||||
| Anteris Technologies Global Corp. | AVR | → 0 | Neutral | 1.637.356 $ | -589.232 $ | -26,5 % | 1 | 2.226.588 $ | -268.412 $ | -10,8 % | 1 | 2.495.000 $ | +245.000 $ | +10,9 % | 1 |
| Contineum Therapeutics, Inc. | CTNM | → 0 | Neutral | 2.425.999 $ | +513.871 $ | +26,9 % | 1 | 1.912.128 $ | +340.583 $ | +21,7 % | 1 | 1.571.545 $ | -10.228 $ | -0,6 % | 1 |
| AMARIN CORP PLC\UK | AMRN | → 0 | Stark | 2.316.018 $ | +180.059 $ | +8,4 % | 1 | 2.135.959 $ | -266.925 $ | -11,1 % | 1 | 2.402.884 $ | -337.097 $ | -12,3 % | 1 |
| Lipocine Inc. | LPCN | → 0 | Neutral | 755.172 $ | -1.601.790 $ | -68,0 % | 1 | 2.356.962 $ | +2.356.962 $ | 1 | |||||
| MARAVAI LIFESCIENCES HOLDINGS, INC. | MRVI | → 0 | Neutral | 2.335.392 $ | +1.501.160 $ | +179,9 % | 1 | ||||||||
| Evommune, Inc. | EVMN | → 0 | Neutral | 2.318.573 $ | +1.061.480 $ | +84,4 % | 1 | 1.257.093 $ | +1.257.093 $ | 1 | |||||
| Evolus, Inc. | EOLS | → 0 | Neutral | 2.288.292 $ | -6.768.877 $ | -74,7 % | 1 | ||||||||
| Vir Biotechnology, Inc. | VIR | → 0 | Neutral | 1.596.121 $ | -643.879 $ | -28,7 % | 1 | 2.240.000 $ | +2.240.000 $ | 1 | |||||
| SUTRO BIOPHARMA, INC. | STRO | → 0 | Schwach | 1.822.441 $ | -417.175 $ | -18,6 % | 1 | 2.239.616 $ | +249.840 $ | +12,6 % | 1 | ||||
| SPRUCE BIOSCIENCES, INC. | SPRB | → 0 | Neutral | 2.160.000 $ | +2.160.000 $ | 1 | |||||||||
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 1.239.813 $ | -467.904 $ | -27,4 % | 1 | 1.707.717 $ | -445.747 $ | -20,7 % | 1 | 2.153.464 $ | +1.161.358 $ | +117,1 % | 1 |
| Savara Inc | SVRA | → 0 | Schwach | 1.259.276 $ | -838.805 $ | -40,0 % | 1 | 2.098.081 $ | +1.071.805 $ | +104,4 % | 1 | 1.026.276 $ | +1.026.276 $ | 1 | |
| RELMADA THERAPEUTICS, INC. | RLMD | → 0 | Neutral | 644.889 $ | -1.289.288 $ | -66,7 % | 1 | 1.934.177 $ | +1.934.177 $ | 1 | |||||
| ProQR Therapeutics N.V. | PRQR | → 0 | Neutral | 1.901.413 $ | +1.901.413 $ | 1 | |||||||||
| INOVIO PHARMACEUTICALS, INC. | INO | → 0 | Schwach | 1.138.896 $ | -662.630 $ | -36,8 % | 1 | 1.801.526 $ | +1.801.526 $ | 1 | |||||
| Rapport Therapeutics, Inc. | RAPP | → 0 | Neutral | 1.797.129 $ | -2.466.751 $ | -57,9 % | 1 | ||||||||
| NovoCure Ltd | NVCR | → 0 | Schwach | 1.470.595 $ | -93.651 $ | -6,0 % | 1 | 1.564.246 $ | +1.564.246 $ | 1 | |||||
| uniQure N.V. | QURE | → 0 | Neutral | 1.503.283 $ | -49.708.979 $ | -97,1 % | 1 | ||||||||
| Passage BIO, Inc. | PASG | → 0 | 1.032.911 $ | -456.603 $ | -30,7 % | 1 | 1.489.514 $ | +1.489.514 $ | 1 | ||||||
| Editas Medicine, Inc. | EDIT | → 0 | Neutral | 1.486.541 $ | +767.971 $ | +106,9 % | 1 | 718.570 $ | +122.186 $ | +20,5 % | 1 | 596.384 $ | +596.384 $ | 1 | |
| Whitehawk Therapeutics, Inc. | WHWK | → 0 | Neutral | 1.389.141 $ | +330.681 $ | +31,2 % | 1 | 1.058.460 $ | +428.633 $ | +68,1 % | 1 | 629.827 $ | +629.827 $ | 1 | |
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 1.300.285 $ | +1.300.285 $ | 1 | |||||||||
| BICYCLE THERAPEUTICS PLC | BCYC | → 0 | Neutral | 808.632 $ | -76.286 $ | -8,6 % | 1 | 884.918 $ | -381.800 $ | -30,1 % | 1 | 1.266.718 $ | -238.248 $ | -15,8 % | 1 |
| NOVAVAX INC | NVAX | → 0 | Sehr schwach | 1.217.798 $ | -890.607 $ | -42,2 % | 1 | ||||||||
| Immunocore Holdings plc | IMCR | → 0 | Neutral | 1.183.026 $ | +1.183.026 $ | 1 | |||||||||
| PLIANT THERAPEUTICS, INC. | PLRX | → 0 | Neutral | 1.016.224 $ | -106.972 $ | -9,5 % | 1 | 1.123.196 $ | +95.928 $ | +9,3 % | 1 | 1.027.268 $ | -193.131 $ | -15,8 % | 1 |
| eHealth, Inc. | EHTH | → 0 | Neutral | 603.232 $ | +318.252 $ | +111,7 % | 1 | 284.980 $ | -738.842 $ | -72,2 % | 1 | 1.023.822 $ | +470.754 $ | +85,1 % | 1 |
| DIVERSIFIED HEALTHCARE TRUST | DHC | → 0 | Schwach | 1.004.519 $ | +1.004.519 $ | 1 | |||||||||
| Helus Pharma Inc. | HELP | → 0 | Neutral | 967.724 $ | +967.724 $ | 1 | |||||||||
| Odyssey Therapeutics, Inc. | ODTX | → 0 | Neutral | 929.101 $ | +929.101 $ | 1 | |||||||||
| InMode Ltd. | INMD | → 0 | Neutral | 926.738 $ | +16.869 $ | +1,9 % | 1 | 909.869 $ | +909.869 $ | 1 | |||||
| SS Innovations International, Inc. | SSII | → 0 | 457.152 $ | -93.633 $ | -17,0 % | 1 | 550.785 $ | +122.752 $ | +28,7 % | 1 | 428.033 $ | +428.033 $ | 1 | ||
| AtaiBeckley Inc. | ATAI | → 0 | 539.806 $ | +539.806 $ | 1 | ||||||||||
| SelectQuote, Inc. | SLQT | → 0 | Stark | 268.974 $ | +43.826 $ | +19,5 % | 1 | 225.148 $ | -279.154 $ | -55,4 % | 1 | 504.302 $ | +504.302 $ | 1 | |
| Akebia Therapeutics, Inc. | AKBA | → 0 | Neutral | 486.888 $ | +486.888 $ | 1 | |||||||||
| RETRACTABLE TECHNOLOGIES INC | RVP | → 0 | 418.262 $ | +33.984 $ | +8,8 % | 1 | 384.278 $ | -64.250 $ | -14,3 % | 1 | 448.528 $ | +142.617 $ | +46,6 % | 1 | |
| Ceribell, Inc. | CBLL | → 0 | Neutral | 374.871 $ | +178.461 $ | +90,9 % | 1 | ||||||||
| GH Research PLC | GHRS | → 0 | Neutral | 233.103 $ | +233.103 $ | 1 | |||||||||
| Airsculpt Technologies, Inc. | AIRS | → 0 | Schwach | 209.813 $ | +209.813 $ | 1 | |||||||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Sehr schwach | 184.800 $ | +184.800 $ | 1 | |||||||||
| Gesamt | 1.922.734.293 $ | +283.073.026 $ | +77,3 % | 118 | 1.823.011.658 $ | +150.616.384 $ | +18,6 % | 112 | 1.941.694.991 $ | +593.482.134 $ | +55,1 % | 105 | |||